February 2019 Briefing - Pulmonology

Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

ATS Issues Practice Guideline for Pediatric Home Oxygen Therapy

THURSDAY, Feb. 28, 2019 (HealthDay News) -- Recommendations have been developed for home oxygen therapy in children with chronic respiratory conditions; the clinical practice guideline from the American Thoracic Society was published in the Feb. 1 issue of the American Journal of Respiratory and Critical Care Medicine.

Abstract/Full Text

Intervention Can Reduce Racial Differences in Lung Cancer Care

THURSDAY, Feb. 28, 2019 (HealthDay News) -- An intervention that includes race-specific feedback and real-time electronic warnings can reduce racial differences in care for early-stage lung cancer, according to a study published online Feb. 4 in Cancer Medicine.

Abstract/Full Text

Stewardship Programs Decrease Inpatient Fluoroquinolone Rx

WEDNESDAY, Feb. 27, 2019 (HealthDay News) -- Fluoroquinolone stewardship interventions at hospitals are associated with less fluoroquinolone prescribing during hospitalization but not at discharge, according to a study published online Feb. 13 in Clinical Infectious Diseases.

Abstract/Full Text

Antenatal Corticosteroid Tx Tied to Reduction in Birth Size

WEDNESDAY, Feb. 27, 2019 (HealthDay News) -- Antenatal corticosteroid therapy (ACT) is associated with reductions in birth size for infants, according to a study published online Feb. 26 in PLOS Medicine.

Abstract/Full Text

Environmental Exposures Before, After Birth Tied to Lung Function

TUESDAY, Feb. 26, 2019 (HealthDay News) -- Exposure to several chemicals before and after birth appears to be associated with a decrease in lung function later in childhood, according to a study published in the February issue of The Lancet Planetary Health.

Abstract/Full Text
Editorial

2014 to 2017 Saw Improvement in Burnout for U.S. Physicians

MONDAY, Feb. 25, 2019 (HealthDay News) -- From 2014 to 2017, there was an improvement in burnout and satisfaction with work-life integration among U.S. physicians, according to a study published online Feb. 22 in the Mayo Clinic Proceedings.

Abstract/Full Text

National Health Spending Set to Increase 5.5 Percent Annually

FRIDAY, Feb. 22, 2019 (HealthDay News) -- National health spending is projected to increase at an annual rate of 5.5. percent from 2018 to 2027, with fundamental economic and demographic factors the main drivers, according to a report published online Feb. 20 in Health Affairs.

Abstract/Full Text (subscription or payment may be required)

Most Patients Do Not Disclose Complementary Medicine Use

FRIDAY, Feb. 22, 2019 (HealthDay News) -- Just one-third of users of biologically based complementary medicine (CM) disclose their use to traditional health care providers, according to a review published online Feb. 7 in Scientific Reports.

Abstract/Full Text

Excessively Sleepy OSA Subtype Tied to Increased CVD Risk

FRIDAY, Feb. 22, 2019 (HealthDay News) -- Obstructive sleep apnea (OSA) patients with excessive daytime sleepiness are at a substantially increased risk for cardiovascular disease (CVD) compared with individuals with other OSA subtypes, according to a study published online Feb. 15 in the American Journal of Respiratory and Critical Care Medicine.

Abstract/Full Text (subscription or payment may be required)

U.S. Agencies Probing Johnson & Johnson Over Asbestos in Talc

THURSDAY, Feb. 21, 2019 (HealthDay News) -- Johnson & Johnson is being investigated by the U.S. Justice Department and the U.S. Securities and Exchange Commission over possible asbestos contamination of the company's baby powder and other talc-based products.

The New York Times Article
More Information - American Cancer Society

Rivaroxaban Does Not Reduce VTE Incidence in High-Risk Cancer Patients

THURSDAY, Feb. 21, 2019 (HealthDay News) -- In high-risk ambulatory patients with cancer, the incidence of venous thromboembolism or death due to venous thromboembolism during 180 days is not significantly reduced for rivaroxaban compared with placebo, according to a study published in the Feb. 21 issue of the New England Journal of Medicine.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Vertical Integration Has Little Impact on Quality Measures

THURSDAY, Feb. 21, 2019 (HealthDay News) -- Vertical integration between hospitals and physicians has little impact on quality measures, while increased hospital market concentration is strongly associated with reduced quality in measures of patient satisfaction, according to a study published online Feb. 9 in Medical Care Research and Review.

Abstract/Full Text

Experimental Test May Quickly Diagnose Sepsis

WEDNESDAY, Feb. 20, 2019 (HealthDay News) -- A blood test that can quickly diagnose dangerous sepsis infections has been developed, according to research published in the Feb. 1 issue of Biosensors and Bioelectronics.

CNN Article
Abstract/Full Text

New Kaiser Permanente Medical School Plans to Waive Tuition

WEDNESDAY, Feb. 20, 2019 (HealthDay News) -- A new medical school to be opened by California-based health system Kaiser Permanente will waive tuition for all students in its first five graduating classes.

The New York Times Article
More Information

Black-White Cancer Mortality Gap Decreasing in Some Age Groups

WEDNESDAY, Feb. 20, 2019 (HealthDay News) -- Cancer death rates are decreasing faster in blacks than whites in the United States, according to a report published online Feb. 14 in CA: A Cancer Journal for Clinicians.

Abstract/Full Text

Hospital Prices Growing Faster Than Physician Prices

FRIDAY, Feb. 15, 2019 (HealthDay News) -- Growth in hospital prices and payments outpaced growth in physician prices and payments from 2007 through 2014, according to a report published in the February issue of Health Affairs.

Abstract/Full Text (subscription or payment may be required)

CDC: Severity of Influenza Season Low Through Feb. 2, 2019

THURSDAY, Feb. 14, 2019 (HealthDay News) -- The 2018 to 2019 influenza season has been low in severity so far, and overall vaccine effectiveness is about 47 percent, according to two reports published in the Feb. 15 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Abstract/Full Text - Blanton
Abstract/Full Text - Doyle

Physical Activity Down Across Chronic Disease Subgroups

THURSDAY, Feb. 14, 2019 (HealthDay News) -- People with a wide variety of chronic diseases are less physically active than individuals without chronic diseases, according to a study published online Feb. 5 in the International Journal of Epidemiology.

Abstract/Full Text

Coexisting Medical Conditions, Smoking Explain PTSD-CVD Link

WEDNESDAY, Feb. 13, 2019 (HealthDay News) -- The correlation between posttraumatic stress disorder (PTSD) and cardiovascular disease (CVD) is not independent and is explained by physical and psychiatric conditions and smoking, according to a study published online Feb. 13 in the Journal of the American Heart Association.

Abstract/Full Text

Guidelines Updated for Pulmonary Arterial Hypertension in Adults

WEDNESDAY, Feb. 13, 2019 (HealthDay News) -- In the latest evidence-based guideline from the American College of Chest Physicians, published online Jan. 17 in CHEST, updated recommendations are provided for the management of adults with pulmonary arterial hypertension (PAH).

Abstract/Full Text

Larger Physician Bonus May Improve Care in Chronic Disease

TUESDAY, Feb. 12, 2019 (HealthDay News) -- Increased bonus size for physicians caring for patients with chronic disease is associated with improvements in care quality, according to a study published online Feb. 8 in JAMA Network Open.

Abstract/Full Text

Health Care Spending Per Person Increased to $5,641 in 2017

TUESDAY, Feb. 12, 2019 (HealthDay News) -- In 2017, health care spending per person reached $5,641, according to the Health Care Cost Institute (HCCI) annual Health Care Cost and Utilization Report.

Health Care Cost and Utilization Report

Many Systematic Reviews Do Not Fully Report Adverse Events

TUESDAY, Feb. 12, 2019 (HealthDay News) -- Many systematic review protocols in the International Prospective Register of Systematic Reviews (PROSPERO) do not include adverse event reporting, according to a study published in the April issue of the Journal of Clinical Epidemiology.

Abstract/Full Text

Low Fitness, Obesity Linked to Later Disability Pension

MONDAY, Feb. 11, 2019 (HealthDay News) -- Among men, low cardiorespiratory fitness and obesity in adolescence are associated with an increased risk for later receipt of a disability pension, according to a study published online Feb. 12 in the Annals of Internal Medicine.

Abstract/Full Text (subscription or payment may be required)

Children With Autism More Often Have Sleep Problems

MONDAY, Feb. 11, 2019 (HealthDay News) -- More children with autism spectrum disorder (ASD) have sleep problems compared with other children, according to a study published online Feb. 11 in Pediatrics.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Johnson & Johnson to Provide Drug Prices in TV Ads

FRIDAY, Feb. 8, 2019 (HealthDay News) -- In a drug industry first, Johnson & Johnson will start giving the list prices of its prescription drugs in television ads.

AP News Article

Drug Combo Tolerated in Younger Children With Cystic Fibrosis

THURSDAY, Feb. 7, 2019 (HealthDay News) -- Lumacaftor/ivacaftor treatment is generally safe and well tolerated for children aged 2 to 5 years with cystic fibrosis (CF) homozygous for the F508del-CFTR mutation, according to a study published online Jan. 24 in The Lancet Respiratory Medicine.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Omadacycline Noninferior to Moxifloxacin for Pneumonia

WEDNESDAY, Feb. 6, 2019 (HealthDay News) -- Omadacycline is noninferior to moxifloxacin for community-acquired bacterial pneumonia and noninferior to linezolid for acute bacterial skin infections, according to two studies published in the Feb. 7 issue of the New England Journal of Medicine.

Abstract/Full Text - Stets (subscription or payment may be required)
Abstract/Full Text - O'Riordan (subscription or payment may be required)
Editorial (subscription or payment may be required)

E-Cigarette Use Linked to Cigarette Initiation in Adolescents

MONDAY, Feb. 4, 2019 (HealthDay News) -- Electronic cigarette use is associated with an increased risk for cigarette initiation and use in adolescents, according to a study published online Feb. 1 in JAMA Network Open.

Abstract/Full Text

Pharmacist-Led Phone Follow-Up May Cut Readmission Rates

FRIDAY, Feb. 1, 2019 (HealthDay News) -- A pharmacist-led, postdischarge structured telephone follow-up (TFU) intervention can reduce 30-day and 90-day readmission rates for polypharmacy patients, according to a study published online Jan. 23 in the British Journal of Clinical Pharmacology.

Abstract/Full Text

Minimal Benefit for Decision Aid About Prolonged Ventilation

FRIDAY, Feb. 1, 2019 (HealthDay News) -- A personalized web-based decision aid about prolonged mechanical ventilation does not improve prognostic concordance between clinicians and surrogate decision makers, according to a study published online Jan. 29 in the Annals of Internal Medicine.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Last Updated: